NasdaqCM - Nasdaq Real Time Price • USD
Atossa Therapeutics, Inc. (ATOS)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:17 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-19,893.0000
-20,760.0000
-16,472.0000
-11,570.0000
Investing Cash Flow
-2,022.0000
-4,727.0000
-9.0000
-9.0000
Financing Cash Flow
-1,475.0000
--
113,304.0000
38,552.0000
End Cash Position
94,087.0000
111,000.0000
136,487.0000
39,664.0000
Capital Expenditure
-22.0000
-27.0000
-9.0000
-9.0000
Issuance of Capital Stock
--
--
69,668.0000
38,566.0000
Free Cash Flow
-19,915.0000
-20,787.0000
-16,481.0000
-11,579.0000
12/31/2020 - 11/8/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SLS SELLAS Life Sciences Group, Inc.
1.4600
-3.95%
JAGX Jaguar Health, Inc.
0.1800
+5.88%
OCGN Ocugen, Inc.
1.2800
+8.47%
CTXR Citius Pharmaceuticals, Inc.
0.6648
-9.25%
TCON TRACON Pharmaceuticals, Inc.
1.8100
+1.12%
CADL Candel Therapeutics, Inc.
6.39
-0.62%
AKBA Akebia Therapeutics, Inc.
1.3400
+0.75%
XFOR X4 Pharmaceuticals, Inc.
1.1650
+3.10%
EYEN Eyenovia, Inc.
0.6282
-11.68%
TNXP Tonix Pharmaceuticals Holding Corp.
0.1685
+5.31%